Rose Pharmaco Pvt Ltd - pharma in Guwahati, Assam, India. FY 2026 financials & compliance.
CIN U51109AS2000PTC018576 Incorporated 01 March 2000 ROC Guwahati HQ Guwahati, Assam, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹1.86 Cr
▲ 20% YoY
Net profit · FY 2024
₹2.92 Lakh
Net margin 1.6%
EBITDA · FY 2024
₹6.33 Lakh
EBITDA margin 3.4%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹37.74 Lakh
Issued & subscribed
Company age
26 yrs
Est. 2000
Employees · EPFO
9
Provident fund records
Directors on board
3
As per MCA filings

About Rose Pharmaco Pvt Ltd

Data last updated:

Rose Pharmaco Pvt Ltd is a private limited company based in Guwahati, Assam, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 March 2000 and has been in existence for over 26 years.

The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U51109AS2000PTC018576. Its GSTIN is 18AACCR1841D1ZP (Assam). The company holds 4 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹37.74 Lakh. It is led by directors including Rosy Paul and Rajib Paul.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No.39 Krishna Nagar Chatribari, Guwahati, Assam, India – 781008.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.86 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹2.92 Lakh (net margin 1.6%) and EBITDA of ₹6.33 Lakh (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 2% over five years.

The company has about 9 employees on its provident fund (EPFO) records.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Rose Pharmaco Pvt Ltd
CIN U51109AS2000PTC018576
Registration Number 018576
Incorporation Date 01 March 2000
ROC Guwahati
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    House No.39 Krishna Nagar Chatribari, Guwahati, Assam, India – 781008
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Rose Pharmaco Pvt Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Rose Pharmaco Pvt Ltd report

Financials, compliance, directors, charges, ownership and filings for Rose Pharmaco Pvt Ltd in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Rose Pharmaco Pvt Ltd

The main business activity of Rose Pharmaco is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Rose Pharmaco Pvt Ltd FY 2025 filings available

Rose Pharmaco Pvt Ltd reported revenue of ₹1.86 Cr (up 20% YoY) for FY 2024.

Revenue · FY 2024
₹1.86 Cr ▲ 20%
Net profit · FY 2024
₹2.92 Lakh margin 1.6%
EBITDA · FY 2024
₹6.33 Lakh margin 3.4%

Compounded Annual Growth Rate (CAGR) of Rose Pharmaco Pvt Ltd

Revenue CAGR growth
1 year
▲ 20%
3 years · compounded
▼ 12%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▼ 36%
3 years · compounded
▲ 28%
5 years · compounded
▲ 25%

Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 20% growth in the latest year. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Rose Pharmaco Pvt Ltd

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹6.33 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹2.92 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Rose Pharmaco Pvt Ltd

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin3.4%••••••••••••••••
Net Profit Margin1.6%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rose Pharmaco are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Rose Pharmaco Pvt Ltd

Rose Pharmaco Pvt Ltd is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Scribemedics Solutions Private Limited₹1.87 Cr (FY 2024)••••••••51.0%••••Chennai, Tamil Nadu, India
Uniprogen Biotech Private Limited₹1.87 Cr (FY 2020)••••••••-30.0%••••Navi Mumbai, Maharashtra, India
Mo Medicine (OPC) Private Limited₹1.87 Cr (FY 2025)••••••••80.0%••••Bhubaneswar, Odisha, India
Astorion Pharmaceuticals Private Limited₹1.87 Cr (FY 2025)••••••••16.0%••••Hyderabad, Telangana, India
Emergent Health Care Private Limited₹1.86 Cr (FY 2025)••••••••16.0%••••Kota, Rajasthan, India
Rose Pharmaco Pvt Ltd this company₹1.86 Cr (FY 2024)••••••••20.0%••••Guwahati, Assam, India
Asset Infotech Limited₹1.86 Cr (FY 2025)••••••••-9.0%••••Dehradun, Uttarakhand, India
Catholicon Pharmaceuticals Private Limited₹1.86 Cr (FY 2025)••••••••-19.0%••••Chandigarh, India
Drakt Marketing Pvt. Ltd.₹1.85 Cr (FY 2022)••••••••4.0%••••Kolkata, West Bengal, India
Elixir Remedies Private Limited₹1.85 Cr (FY 2024)••••••••342.0%••••Ahmedabad, Gujarat, India
Diaitasure Global Private Limited₹1.85 Cr (FY 2025)••••••••155.0%••••Thane, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Rose Pharmaco by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Rose Pharmaco Pvt Ltd

Rose Pharmaco Pvt Ltd is audited by R.K.KEDIA & ASSOCIATES for the financial year 2023.

NameStatusAppointment DateCessation Date
R.K.KEDIA & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Rose Pharmaco Pvt Ltd

Rose Pharmaco has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Rosy PaulDirector02 Jun 20233 Years 4 MonthsCurrent
Rajib PaulDirector01 Mar 200026 Years 7 MonthsCurrent
Joysmita PaulDirector01 Mar 200026 Years 7 MonthsCurrent

Ownership and Shareholding of Rose Pharmaco Pvt Ltd

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Rose Pharmaco Pvt Ltd

Rose Pharmaco Pvt Ltd does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Rose Pharmaco Pvt Ltd

Rose Pharmaco Pvt Ltd has a workforce of 9 employees as of Apr 02, 2024.

Employee count
9
Active EPFO establishments
1
Employee growth
28.57%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

CIN History of Rose Pharmaco Pvt Ltd

Rose Pharmaco has one previous CIN (Corporate Identification Number): U51109WB2000PTC091239. The current CIN is U51109AS2000PTC018576, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U51109AS2000PTC018576Current
U51109WB2000PTC091239Previous

Recent Activity on Rose Pharmaco Pvt Ltd

Rose Pharmaco Pvt Ltd has 3 board changes on record since 2000: 3 appointments. The latest: Rosy Paul was appointed as Director on 02 Jun 2023.

AGM
Rose Pharmaco Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rose Pharmaco Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Guwahati.
Appointed
Rosy Paul was appointed as Director.
Appointed
Joysmita Paul was appointed as Director.
Appointed
Rajib Paul was appointed as Director.
Incorporation
01 Mar 2000
Rose Pharmaco Pvt Ltd was registered on 01 Mar 2000 with Roc Guwahati & aged 26 years 7 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Rose Pharmaco Pvt Ltd

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Rose Pharmaco Pvt Ltd

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Rose Pharmaco Pvt Ltd

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Rose Pharmaco Pvt Ltd

Rose Pharmaco has 4 GST registrations: 2 active and 2 cancelled or inactive.

Total GSTINs
4
Active
2
Cancelled / inactive
2
GSTINStateStatusRegistered on
18AACCR1841D1ZPAssamActive01 Jul 2017
27AACCR1841D1ZQMaharashtraActive18 Jan 2022
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Rose Pharmaco Pvt Ltd

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rose Pharmaco Pvt Ltd

Rose Pharmaco is an active private limited company based in Guwahati, Assam, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 March 2000 (26+ years old) and is registered under CIN U51109AS2000PTC018576.

Rose Pharmaco reported revenue of ₹1.86 Cr for FY 2024 (up 20% YoY).

Rose Pharmaco has 3 current directors:

Rose Pharmaco reported a net profit of ₹2.92 Lakh (net margin 1.6%) and EBITDA of ₹6.33 Lakh (EBITDA margin 3.4%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Rose Pharmaco is -12% over three years and 2% over five years. In the latest year (FY 2024) revenue rose 20%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Rose Pharmaco is 18AACCR1841D1ZP, registered in Assam. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 27AACCR1841D1ZQ (Maharashtra).

The CIN (Corporate Identification Number) of Rose Pharmaco is U51109AS2000PTC018576. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Rose Pharmaco was incorporated on 01 March 2000, making it 26+ years old. It is registered with the Registrar of Companies, Guwahati.

The peers of Rose Pharmaco by revenue are Scribemedics Solutions Private Limited, Uniprogen Biotech Private Limited, Mo Medicine (OPC) Private Limited, Astorion Pharmaceuticals Private Limited, Emergent Health Care Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Rosy Paul was appointed as Director on 02 Jun 2023. Joysmita Paul was appointed as Director on 01 Mar 2000. Rajib Paul was appointed as Director on 01 Mar 2000.

The registered office of Rose Pharmaco is at House No.39 Krishna Nagar Chatribari, Guwahati, Assam, India – 781008.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available